Natixis Envista Holdings Corp Transaction History

Natixis

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$32.84 - $42.5 $1.31 Million - $1.7 Million	40,000 New	40,000 $1.64 Million
Q1 2022 May 13, 2022	SELL	$41.4 - $50.9 $353,556 - $434,686	-8,540 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$37.73 - $46.74 $5.14 Million - $6.36 Million	-136,112 Reduced 94.1%	8,540 $385,000
Q3 2021 Nov 12, 2021	BUY	$39.75 - $44.09 $5.75 Million - $6.38 Million	144,652 New	144,652 $6.05 Million
Q1 2021 May 14, 2021	SELL	$32.95 - $41.63 $7.26 Million - $9.17 Million	-220,252 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$24.49 - $33.73 $5.39 Million - $7.43 Million	220,252 New	220,252 $7.43 Million
Q1 2020 May 14, 2020	SELL	$11.91 - $33.2 $5.88 Million - $16.4 Million	-493,734 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$26.78 - $30.67 $13.2 Million - $15.1 Million	493,734 New	493,734 $14.5 Million

319

202M

695K

82.6K

Ticker NVST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 163,391,008
Market Cap $3.12B
Description
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.